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Abstract
The biological interaction between copper and iron is best exemplified by the decreased activity of multicopper
ferroxidases under conditions of copper deficiency that limits the availability of iron for erythropoiesis. However, little is
known about how copper deficiency affects iron homeostasis through alteration of the activity of other copper-containing
proteins, not directly connected with iron metabolism, such as superoxide dismutase 1 (SOD1). This antioxidant enzyme
scavenges the superoxide anion, a reactive oxygen species contributing to the toxicity of iron via the Fenton reaction. Here,
we analyzed changes in the systemic iron metabolism using an animal model of Menkes disease: copper-deficient mosaic
mutant mice with dysfunction of the ATP7A copper transporter. We found that the erythrocytes of these mutants are
copper-deficient, display decreased SOD1 activity/expression and have cell membrane abnormalities. In consequence, the
mosaic mice show evidence of haemolysis accompanied by haptoglobin-dependent elimination of haemoglobin (Hb) from
the circulation, as well as the induction of haem oxygenase 1 (HO1) in the liver and kidney. Moreover, the hepcidin-
ferroportin regulatory axis is strongly affected in mosaic mice. These findings indicate that haemolysis is an additional
pathogenic factor in a mouse model of Menkes diseases and provides evidence of a new indirect connection between
copper deficiency and iron metabolism.
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Introduction
Copper and iron are essential biometals, both existing in two
main oxidation states, i.e. Cu(I)/Cu(II) and Fe(II)/Fe(III). The
extensive range of redox potential available to both metals by
varying their interactions with coordinating ligands, as well as their
capacity to participate in one-electron transfer reactions, are the
reasons why copper and iron are essential for almost all living
organisms. Both metals serve as cofactors for enzymes that
catalyze diverse redox reactions underlying fundamental metabolic
processes, including respiratory oxidation, DNA, microRNA and
neurotransmitter synthesis, oxygen radical scavenging and con-
nective tissue formation [1,2].
In mammals, iron is much more abundant than copper [3],
mainly because it is an essential component of haem in the
oxygen-carrying molecules haemoglobin and myoglobin. On the
other hand, the biological activities of copper and iron also have a
toxic aspect, since both cuprous [Cu(I)] and ferrous [Fe(II)] ions
are able to react with hydrogen peroxide in the Fenton cycle,
yielding the highly destructive hydroxyl radical, the most reactive
free radical species known. It is therefore vital that copper and iron
are carefully sequestered and transported to their intracellular
destinations. Regulatory systems have evolved to maintain iron [1]
and copper [2] homeostasis. Interestingly, some pathways of iron
homeostasis largely depend on the activity of copper-containing
ferroxidases such as caeruloplasmin (Cp) and hephaestin. The
former is mainly synthesized in hepatocytes in the form of apo-Cp.
Incorporation of copper into apo-Cp results in the formation of the
redox-active holoenzyme and is mediated by the P-type ATPase,
ATP7B during transit through the trans-Golgi network. Cp is then
secreted to the circulation where it functions to deliver copper to
other tissues. Although Cp-bound copper accounts for about 90%
of the total serum copper, it is not indispensable for efficient
copper distribution in the body [3,4,5]. It has been shown that an
alternative spliced glycosylphosphatidylinositol (GPI) variant of Cp
(Cp-GPI) originally characterized in the brain [6] is of particular
importance for iron metabolism [3,5]. Cp-GPI cooperates with
ferroportin (Fpn), the sole cellular iron exporter known in
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mammals [7], to facilitate the movement of iron out of cells. First,
ferrous ions transported into the circulation by ferroportin are
oxidized by Cp-GP1 and ferric ions are then bound by transferrin.
Second, Cp-GPI is required for the stability of cell surface
ferroportin [8].
Copper deficiency has not been reported to significantly and
directly influence ferroportin gene expression [9,10], but on the
other hand, treatment of J774 macrophage cells with copper has
been shown to induce ferroportin and to increase iron efflux from
these cells [11]. The cooperation Cp-GPI and ferroportin is crucial
for iron recycling by reticuloendothelial cells and iron release by
hepatocytes [3]. The role of Cp in iron metabolism has been
reported in the congenital human disease acaeruloplasminemia, in
which mutations in the caeruloplasmin gene lead to hypoferraemia
and iron loading in the liver [12,13]. Hepatic iron overload also
occurs in acquired copper deficiency and is likely mediated by
hypocaeruloplasminemia [14]. Furthermore, iron overload was
reported in Wilson disease, a genetic disorder caused by the
mutation in ATP7B gene. The lack of ATP7B activity in patients
with Wilson disease results in impaired copper loading to apo-Cp
and in consequence in decreased Cp ferroxidase activity [15].
Hephaestin shares 50% homology with Cp and is a ferroxidase
required for the egress of iron from intestinal enterocytes into the
circulation. Sex-linked anaemia (sla) mice, carrying mutations in
the gene encoding hephaeastin develop moderate to severe
microcytic hypochromic anaemia [16]. Systemic iron deficiency
has been also reported in copper-deficient mice displaying
decreased hephaestin ferroxidase activity in the intestine [17].
Evidence of the nutritional requirement for copper in maintaining
iron homeostasis dates back to the study of Hart et al. in 1928, in
which copper was found to be necessary for haemoglobin
formation in rats fed on a copper-deficient milk-based diet [18].
Numerous examples of the correlation between copper deficiency
and poor iron status have been provided by studies on rapidly
growing suckling piglets [19,20].
In mammals, dietary copper is transferred across the apical
membrane into enterocytes in its reduced (cuprous) form by
copper transporter 1. Transport through the enterocyte basolat-
eral membrane is mediated by ATP7A, a P-type ATPase copper
transporter. In the blood copper is bound to albumin or a2-
macroglobulin and is delivered to the liver via the portal
circulation [21,22]. Copper deficiency is associated with Menkes
disease, a life-threatening pathology in man, which is due to
mutations in the ATP7A gene, resulting in defective functioning of
ATP7A [21,23]. The general pattern of copper content in the
organs of patients with Menkes disease indicates that copper is
scarce in the brain, liver and heart, while it accumulates in the
small intestine and kidneys [23]. This is consistent with the role of
ATP7A as a membrane protein transporting copper out of
duodenal enterocytes [21]. In other cells, under physiological
conditions, this protein is primarily localized to the trans-Golgi
network, but it is also detected in some other post Golgi
compartments [21]. However, when cells are exposed to increased
copper concentrations, ATP7A is trafficked to the plasma
membrane and its main role is to prevent toxic intracellular
accumulation of copper by expelling copper ions from the cell’s
interior [24,25].
Mouse Atp7a mutants closely mimicking patients with Menkes
disease serve as animal models of this inherited disorder and have
recently been extensively used to explore metabolic copper-iron
interactions [26,27]. The mosaic mutation (Atp7amo-ms) belongs to
the group of mottled mutations, which severely affect copper
metabolism, and is caused by mutation of the X-linked Atp7a
gene. In mosaic mutants, a G to C nucleotide exchange in exon 15
of the Atp7a gene results in an arginine to proline substitution in
the highly conserved 6th transmembrane domain of the ATP7A
protein. The mutated protein is mislocalized and is not
translocated to the plasma membrane [28]. Hemizygous mutant
males exhibit a severe phenotype including defects in pigmentation
and hair structure, decreased body weight, and neurological
problems such as ataxia, tremor and progressive paresis of the hind
limbs. The mosaic mutation is usually lethal by day 17 of life [28].
Here, we analyzed potential changes in iron metabolism in
copper-deficient 14-day old male mosaic mutant mice. The
conception of our study was based on the assumption that copper
deficiency may decrease the activity of Cu,Zn-superoxide dis-
mutase (SOD1), an enzyme playing a crucial role in erythrocyte
antioxidant defense, and thus may sensitize these cells to
haemolysis, a pathological condition in which systemic iron
metabolism is seriously affected [29]. Accordingly, we and others
have previously demonstrated that mice with a disrupted Sod1
gene are prone to haemolytic insult [30,31]. Our results show that
mosaic mutant mice exhibit some perturbations in systemic iron
metabolism that are characteristic of moderate haemolysis.
Materials and Methods
Animals
Mice used in these experiments were bred in the Department of
Genetics and Evolution, Jagiellonian University, and derived from
a closed outbred colony. The animals were obtained by mating
heterozygous ms/+ females with normal (+/2) males. The
experimental material consisted of two groups of 14-day-old
control (+/2) and mosaic mutant (ms/2) males. All mice were
housed at constant temperature (22uC) under artificial light (12-
hour photoperiod) and fed a standard Murigran diet (Motycz,
Poland). Experiments were performed in accordance with Polish
legal requirements under the licence of the First Local Ethical
Committee on Animal Testing at the Jagiellonian University in
Krakow (permission number: 85/2012). The animals were
sacrificed by cervical dislocation.
Blood and tissue collection
Blood samples were collected from a neck vein to EDTA-coated
tubes. The EDTA-treated whole blood was used for the immediate
preparation of smears. Blood samples were incubated at 4uC for
2 hours, and then serum and erythrocyte fractions were obtained
by centrifugation at 20006g for 10 min. The liver and kidneys
were excised from mice following laparotomy. Tissue, serum and
red blood cell (RBC) samples were immediately frozen in liquid
nitrogen and stored at 280uC prior to molecular analysis.
Measurement of erythrocyte copper content
The level of copper in erythrocytes from ms/2 and +/2 male
mice was measured by atomic absorption spectrophotometry.
Erythrocyte samples were weighed and digested in 2 ml of boiling
Suprapur-grade nitric acid (Merck). After cooling to room
temperature (RT), each sample was suspended in 10 ml of
deionized water. Reference material samples were prepared in a
similar manner. The copper concentration was measured using
the graphite furnace AAS technique (AAnalyst 800, Perkin-Elmer).
Three samples of nitric acid were used as blanks. In addition, three
samples of a standard reference material, Cu = 18964 mg/kg,
were analyzed for normalization of the obtained data.
Measurement of superoxide dismutase activity
SOD activity in erythrocyte total extracts was measured by gel
electrophoresis using the Nitroblue Tetrazolium (NBT)/riboflavin
Haemolysis and Menkes Disease
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method as described previously [32]. Briefly, 15 mg samples of the
erythrocyte extracts were resolved by electrophoresis on 12%
polyacrylamide gels under non-denaturing and non-reducing
conditions. After electrophoresis, the activity of SOD was
visualized by immersion of the gels in staining buffer [50 mM
potassium phosphate (pH 7.8), 0.1 mM EDTA, 28 mM TEMED,
3 mM riboflavin, 0.25 mM NBT] for 30 min in the dark at RT.
Gels were then exposed to light until the SOD activity bands
became visible as bright bands on a dark blue background. The
reaction was stopped by rinsing the gels with water and they were
scanned and quantified immediately using a Molecular Imager
with Quantity One software (Bio-Rad). The activities of Cu,Zn-
SOD and Mn-SOD were distinguished by selective inhibition of
the former activity by incubation of the gels in a buffer containing
3 mM KCN prior to staining, as described by Salin and Bridges
[33].
Immunoblot analysis
SOD1 was detected in total extracts (15 mg) obtained from
peripheral erythrocytes using rabbit polyclonal anti-superoxide
dismutase 1 antibody (Abcam; ab16831). To determine plasma
haptoglobin (Hp) levels, 7 ml samples of 20-fold diluted mouse
serum were used. Hp was detected with a chicken antibody raised
against human Hp (US Biological). Its cross-reactivity with the
mouse protein was demonstrated previously [31]. Ferritin levels in
cytosolic extracts (20 mg) of mouse liver were analyzed using
purified rabbit mouse liver ferritin antiserum (kindly provided by
Dr. J. Brock, Glasgow University, Glasgow, UK) [34]. Haem
oxygenase 1 (HO1) was detected in hepatic and renal crude
membrane extracts (80 mg) using a rabbit polyclonal antibody
raised against rat liver HO1 (StressGen). Actin, the loading control
for serum and tissue extracts, was detected using an anti-human
goat polyclonal antibody (Sigma; sc1615). Immunoreactive bands
were disclosed using the ECL Plus Western blotting detection
system (Amersham Life Sciences). Reactive bands were quantified
relative to actin using a Molecular Imager with Quantity One
software (Bio-Rad).
Real-time Quantitative RT-PCR
HO1 and hepcidin (Hepc) hepatic mRNAs were measured by
real-time quantitative RT-PCR as described previously [31].
Specific cDNA fragments were amplified using the following pairs
of oligonucleotide primers: HO1, 59-GTCGTGGTCAGTCAA-
CATGG-39 (forward) and 59-TCTTGCCTGGCTCTCTTCTC-
39 (reverse); Hepc, 59-CAATGTCTGCCCTGCTTTCT-39 (for-
ward) and 59-TCTCCTGCTTCTCCTTG-39 (reverse). The
reactions were performed in a Light Cycler (Roche Diagnostics)
and Light Cycler 3.5 Software was used for data analysis.
Expression was quantified relative to that of a control transcript
encoding glyceraldehyde-3-phosphate dehydrogenase [GAPDH;
59-GACCACAGTCCATGCCATCAC-39 (forward) and 59-
TCCACCACCCTGTTGCTGTAG-39 (reverse)].
Quantitative hepatic non-haem iron measurement
The non-haem iron content of liver fragments (100 mg) was
determined by acid digestion of the samples at 100uC for 10 h,
followed by colorimetric measurement of the absorbance of the
iron-ferrozine complex at 560 nm as described previously [35].
Immunofluorescence (IF) and confocal analysis of liver
and kidney sections
After the sacrifice of mice, the liver and kidneys were
immediately excised and fixed in 4% paraformaldehyde (Sigma)
in phosphate-buffered saline (PBS) (Sigma) at 4uC for 24 h. After
washing 3 times for 30 min in PBS, both tissues were successively
soaked in 12.5 and 25% sucrose (Merck) for 1.5 and 12 h,
respectively at 4uC. The tissues were then embedded in Tissue-
Tek compound, frozen in liquid nitrogen and sectioned into 20-
mm slices using a cryostat (Leica). The sections were washed in
PBS and permeabilized by bathing in PBS/0.1% Triton X-100
(Sigma) for 10 min. Non-specific antibody binding was blocked by
incubation of the tissue sections in PBS/3% BSA (Merck) for
1.5 h. For ferroportin (Fpn) detection in the liver, sections were
incubated at RT with primary rabbit polyclonal anti-Fpn antibody
(Alpha Diagnostic) diluted 1:250 in PBS/3% BSA. The sections
were then washed 3 times with PBS and incubated with Cy3
(indocarbocyanine)-conjugated goat anti-rabbit antibody (Jackson
Immunoresearch) diluted 1:500 in PBS/3% BSA. For haem
oxygenase 1 (HO1) detection, liver and kidney sections were
prepared as described above and incubated overnight at RT with
primary rabbit polyclonal anti-HO1 antibody (StressGen) diluted
1:250 in PBS/3% BSA. The sections were washed 3 times with
PBS and then incubated with Cy3-conjugated goat anti-rabbit
antibody diluted 1:500 in PBS/3% BSA. In the liver we also
performed co-labeling of HO1 and Fpn with F4/80, a membrane
macrophage marker [36]. Liver sections were incubated overnight
with either anti-Fpn or with anti-HO-1 antibody and rat anti-
mouse F4/80 monoclonal antibody (Serotec) diluted 1:500 in
PBS/3% BSA. The sections were then incubated with a mixture of
Cy3-conjugated goat anti-rabbit antibody and Alexa 488 goat
anti-rat antibody (Jackson Immunoresearch) in PBS/3% BSA for
1 h. Finally, the sections were washed 3 times for 10 min in PBS at
RT and mounted using Vectashield with 49,6-diamidine-2-
phenylindole (DAPI; Vector Labs). As a negative control, some
sections were prepared without incubating with primary antibody.
IF was analyzed with a Zeiss LSM 510 Meta confocal microscope
(Carl Zeiss, Jena, Germany) using the 60x objective.
Statistical Analysis
Statistical analysis was performed using a two-tailed Student’s t
test, with p values of ,0.05 and ,0.01 being considered
statistically significant and highly significant, respectively.
Results
Copper deficiency and decreased SOD1 activity and
expression in erythrocytes of mutant ms/2 mice
14-day-old mosaic mutant mouse males exhibit a tissue copper
concentration pattern typical of Menkes disease, i.e. reduced levels
in both liver and brain and increased levels in both kidney and
duodenum [37,38]. Here, we analyzed for the first time the copper
content in circulating RBCs of such mutants and found that it was
nearly 60% lower compared to wild-type animals (Figure 1A).
Bearing in mind that the bioavailability of copper is crucial for
maintaining SOD1 activity at the required level [39], we then
assessed the activity of this key antioxidant enzyme in erythrocytes
of both mutant and wild-type males. Similarly to the copper
concentration, SOD1 activity in erythrocytes measured by the
NBT/riboflavin method [32] was substantially reduced in ms/2
mice as shown by densitometry of SOD1 bands (Figure 1B).
Moreover, we found that this decrease was at least partly due to
the reduced SOD1 protein level in mosaic erythrocytes, detected
by western immunoblotting (Figure 1C).
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Haemolysis and haemoglobin (Hb)-scavenging systems
in mutant ms/2 mice
We and others have shown that in SOD1 knock-out (KO) mice,
erythrocytes become sensitive to rupture due to oxidative stress
and, in consequence, KO SOD1 mice display clear signs of
haemolysis [30,31]. Therefore, in the present study we attempted
to identify hallmarks of intravascular haemolysis in ms/2 mice. It
was immediately noticeable that serum obtained from the blood of
ms/2 mice, centrifuged immediately after neck vein puncture, was
a reddish color (Figure 2A). Wright staining of blood smears from
ms/2 mice revealed a large percentage of irregularly-shaped
RBCs, the morphology of which strongly resembled that of
acanthocytes (Figure 2B). We then examined the serum level of
haptoglobin (Hp), an acute phase protein that traps free Hb
released from ruptured erythrocytes and eliminates it from the
circulation [40,41]. In contrast to free Hp, the stable Hp-Hb
complex binds the CD163 receptor with high affinity and is
rapidly delivered mainly to the reticulo-endothelial system by
endocytosis [40,41]. Therefore, a decrease in the Hp concentra-
tion in the serum is generally considered a marker of accelerated
haemolysis [40,41]. Western blot analysis showed that Hp was
completely depleted in the plasma of ms/2 mice (Figure 2C),
suggesting intensive plasma clearance of free Hb.
Increase in hepatic and renal haem oxygenase 1 (HO1)
expression in mutant ms/2 mice
Hb produced by haemolysis is recovered from the circulation by
the liver in a process that entails the transcriptional induction of
HO1 expression [42], which represents the most important
protective system against haem toxicity. A comprehensive
assessment of HO1 expression and localization in the liver clearly
showed significant induction of the Hmox1 gene (coding HO1) at
both the mRNA (Figure 3A) and protein levels (Figure 3B, 3C and
3D) in mosaic mutants. Co-localization studies demonstrated that
Figure 1. Decreased copper content and activity/expression of SOD1 in circulating erythrocytes from ms/2 mice. (A) Decreased
copper content in erythrocytes of ms/2 mice. Values are expressed as the means 6 S.D. for erythrocyte samples obtained from 15 control (+/2) and
15 mutant (ms/2) males. (B) left-hand panel, the activity of SOD was measured after resolution by gel electrophoresis using the Nitroblue Tetrazolium
(NBT)/riboflavin method as described in the Experimental section. The analyses were performed using erythrocyte total extracts obtained from ms/2
and +/2 males and representative results are shown. (C) left-hand panel, SOD1 levels in erythrocytes were analyzed by western blotting as described
in the Experimental section. The analyses were performed using erythrocyte total extracts obtained from ms/2 and control (+/2) males, and
representative results are shown. The blot was reprobed with monoclonal anti-actin antibody as a loading control. (B,C) right-hand panels, the
intensity of the SOD bands was quantified with a molecular Imager using Quantity One software (Bio-Rad) and is plotted in arbitrary units to present
activity (B) and protein level (C). Results are expressed as the mean 6 S.D. for 5 mice of both the ms/2 and +/2 genotypes. Significant differences are
indicated (* – P,0.05; ** – P,0.01).
doi:10.1371/journal.pone.0107641.g001
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HO1 was mainly located in Kupffer cells in both control and
mutant males (identified by staining with the anti-F4/80 antibody
specific for a macrophage membrane marker [36]) (Figure 3D).
Quantitative RT-PCR (Figure 4A) and western blotting (Fig-
ure 4B) analyses showed that HO1 expression was also increased
in the kidney of ms/2 mice. Microscopic analysis of immunoflu-
orescent (IF) staining and transmitted light images indicated that
expression of HO1 in the renal cortex of control males expression
of HO1 occurred mainly in the renal glomeruli (Figure 4 C, upper
panel), whereas in the mutant males, HO1 expression was strongly
up-regulated in the cells of renal tubules (Figure 4C, bottom
panel).
Decreased ferroportin (Fpn) and increased hepcidin
(Hepc) expression in the liver of ms/2 mice
Assessment of the functioning of the Hepc-Fpn axis is an
indispensable element in the analysis of iron metabolism. It has
been reported that Fpn, the sole cellular iron exporter known in
mammalian cells [7], is up-regulated in the liver in various mouse
models of haemolysis [29,31]. Using IF detection we found
substantial hepatic Fpn down-regulation in ms/2 males compared
with control animals (Figure 5A). Confocal analysis of dual
staining with antibodies specific for Fpn and the plasma
membrane macrophage marker F4/80, indicated strong co-
localization, suggesting that Fpn is located in liver macrophages
(Kupffer cells) in both wild-type and mosaic mutant males
(Figure 5B). Detailed analysis of the microscopic images revealed
strong cell membrane localization of Fpn in control animals (Fpn
staining precisely overlaps that of F4/80), whereas membrane
expression of Fpn on Kupffer cells appeared much weaker in the
mutants (Figure 5B, bottom panel). Quantitative RT-PCR anal-
ysis showed an increase in the Hepc mRNA level of about 10-fold
in the livers of ms/2 mice compared with those of +/2 animals.
Assuming that systemic inflammation may be responsible for the
transcriptional induction of Hamp gene expression, it is notewor-
thy that the kidneys of ms/2 males showed clear signs of
inflammation including cellular vacuolization, necrosis of the
renal tubule epithelial cells, lymphocyte infiltration, and damage to
renal glomeruli structures [43,44].
Hepatic and renal iron status in ms/2 mice
In the context of accelerated Hb clearance and the enhanced
capacity to degrade excess haem in the liver and kidneys of ms/2
males, we investigated the consequences of these activities on the
iron status in both organs. Although our data showed a tendency
for hepatic and renal iron accumulation in ms/2 males compared
with +/2 animals (Figure 6A and 6C), the differences in non-haem
iron content between these mice were not significant (P values .
0.05). In general, the ferritin level serves as a marker of iron
loading in cells and tissues [45]. Moreover, it is usually elevated in
Figure 2. Haemolysis and acanthocytosis in ms/2 mice. (A) Serum of control (+/2) and mutant (ms/2) males obtained by centrifugation. (B)
Peripheral blood smears of ms/2 mice showing increased numbers of acanthocytes. High magnification images of a normal and an abnormally-
shaped erythrocyte are shown (insets). Six animals from both the control and ms/2 male groups were examined and one typical sample of each is
shown. Bars correspond to 5 mm. (C) Plasma levels of haptoglobin (Hp) were assessed by western blotting as described in the Experimental section.
The blot was reprobed with monoclonal anti-actin antibody as a loading control.
doi:10.1371/journal.pone.0107641.g002
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Figure 3. Increased expression of haem oxygenase 1 (HO1) in Kupffer cells of ms/2 mice. (A) Real-time quantitative PCR analysis of
hepatic HO1 mRNA expression. The histogram displays HO1 mRNA levels in arbitrary units (means 6 S.D., n = 6). (B) left-hand panel Western blot
analysis of HO1 protein levels in hepatic membrane fractions prepared from +/2 and ms/2 males. The blot was reprobed with polyclonal anti-human
actin antibody as a loading control. right-hand panel Immunolabelled HO1 bands from six mice were quantified using a Molecular Imager and HO1
protein levels (means 6 S.D.) are plotted in arbitrary units. * – P,0.05. (C) top panel Immunofluorescent staining of HO1 in +/2 and ms/2 livers
analyzed by confocal microscopy. middle panel Tissue morphology observed in transmitted light. bottom panel To confirm the specificity of Fpn
detection, liver sections of +/2 and ms/2 males were incubated with only the secondary antibody. No HO1 staining was detected in these negative
controls. Nuclei were counterstained with DAPI. Bars correspond to 50 mm. (D) Colocalization (bottom panel) of HO1 (red channel) and F4/80, a
macrophage marker (green channel) in the livers of +/2 and ms/2 males analyzed by confocal microscopy. Nuclei were counterstained with DAPI.
Bars correspond to 50 mm.
doi:10.1371/journal.pone.0107641.g003
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Figure 4. Increased expression of haem oxygenase 1 (HO1) in kidneys of ms/2 mice. (A) Real-time quantitative PCR analysis of renal HO1
mRNA expression. The histogram displays HO1 mRNA levels in arbitrary units (means 6 S.D., n = 6). (B) left-hand panel Western blot analysis of HO1
protein levels in hepatic membrane fractions prepared from +/2 and ms/2 males. The blot was reprobed with polyclonal anti-human actin antibody
as a loading control. right-hand panel Immunolabelled HO1 bands from six mice were quantified using a Molecular Imager and HO1 protein levels
(means 6 S.D.) are plotted in arbitrary units. ** – P,0.01. (C) left-hand panel Immunofluorescent staining of HO1 in +/2 and ms/2 kidneys analyzed
by confocal microscopy. RN – renal tubules; RG – renal glomeruli. middle panel Transmitted light image shows the structure of glomeruli and tubules
as well as the presence of a large lesion (asterisk) in the kidney of a mutant. right-hand panel To confirm the specificity of HO1 detection, kidney
sections of +/2 and ms/2 males were incubated with only the secondary antibody. No HO1 staining was detected in these negative controls. Nuclei
were counterstained with DAPI. Bars correspond to 50 mm.
doi:10.1371/journal.pone.0107641.g004
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the kidneys and liver under conditions of haemolysis [29,46].
Analysis of liver and kidney cytosolic extracts by western blotting
revealed significantly higher ferritin expression in ms/2 males
compared with the control animals (Figure 6B and 6D).
Discussion
The interaction between the multi-copper ferroxidases caer-
uloplasmin and hepheastin, and ferroportin in the egress of iron
from cells is a major biological link between copper and iron, and
the best characterized at the molecular level [3]. It is assumed that
mutation of genes encoding caeruloplasmin and hephaestin as well
as copper deficiency, which decreases the ferroxidase activity of
both enzymes, reduces the amount of iron available for
erythropoiesis and contributes to the accumulation of iron in the
liver, intestine and brain [3]. Another important interaction
between these two biometals is copper-dependent iron utilization
for haemoglobin synthesis by erythroid cells [18], but the
molecular nature of this process is poorly understood [47].
Recently, an additional copper-iron relationship was identified in
mice under conditions of nutritional copper deficiency [48]. This
involves a series of consecutive events such as iron-deficiency
anaemia, hypoxia, stabilization of HIF2-a in duodenal enterocytes
and subsequent transcriptional up-regulation of genes responsible
for enhanced iron absorption [48].
In the present study, we examined the adaptive response of
systemic iron regulation to copper deficiency, which causes altered
activity of the first-line defence antioxidant cuproenzyme, super-
Figure 5. Correlation between decreased ferroportin (Fpn) protein level and increased hepcidin (Hepc) mRNA expression in the
liver of ms/2 males. (A) Immunofluorescent staining of Fpn in +/2 and ms/2 males. top panel Livers analyzed by confocal microscopy. middle
panel Tissue morphology observed in transmitted light. bottom panel To confirm the specificity of Fpn detection, liver sections of +/2 and ms/2
males were incubated with only the secondary antibody. No Fpn staining was detected in these negative controls. Nuclei were counterstained with
DAPI. Bars correspond to 50 mm. (B) Colocalization (bottom panel) of Fpn (red channel) and F4/80, a macrophage marker (green channel) in liver from
+/2 and ms/2 males analyzed by confocal microscopy. Nuclei were counterstained with DAPI. Bars correspond to 50 mm. (C) Real-time quantitative
PCR analysis of hepatic Hepc mRNA expression in +/2 and ms/2 males. The histogram displays Hepc mRNA levels in arbitrary units (means 6 S.D.,
n = 6). Significant difference is indicated (** – P,0.01).
doi:10.1371/journal.pone.0107641.g005
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oxide dismutase 1 (SOD1, Cu,Zn-SOD), a scavenger of the
superoxide anion radical (O2
.2) [49]. Previous study performed on
10 and 11-day-old mice showed that both dietary copper
deficiency in wild-type mice and copper insufficiency in brindled
mutant mice (Atp7amo-br) lead to the decrease in SOD1 activity in
many organs such as liver, spleen, brain, heart, thymus and bone
marrow [50]. Decrease in SOD1 activity was also described in
organs of 13-day old brindled and blotchy (Atp7amo-blo) mutant
males [51]. This study was designed to test whether copper
deficiency is responsible for decreased SOD1 activity in erythro-
cytes, resulting in membrane damage, haemolysis and subsequent
changes in systemic iron metabolism. This hypothesis was
formulated in the light of the following information: 1) SOD1-
associated copper accounts for more than half of the total copper
content in circulating erythrocytes [52]; 2) nutritional copper
deficiency has been shown to decrease both the expression and
activity of SOD1 in erythrocytes [39]; 3) we [31] and others [30]
have demonstrated the occurrence of haemolysis in mice lacking
Cu,Zn-SOD; and 4) haemolysis entails substantial changes in iron
metabolism [29].
In our experiments we used a well characterized mosaic mouse
line, representing a model of Menkes disease, which carries a
mutation in the Atp7a gene and therefore lacks the ATP7A
copper-transporting P-type ATPase [28]. When untreated with
copper, mosaic mutant hemizygous males die by day 17 of life [28]
and so we used 14-day-old animals in our study. Their pattern of
body copper content and distribution is typical for Menkes disease,
i.e. increased copper accumulation in the small intestine and
kidneys, and severe copper deficiency in the brain, liver and heart
[37,38]. To our knowledge, erythrocyte copper content has never
been described in patients with Menkes disease or in mouse
models of this condition. Considering that the duodenal ATP7A
transporter plays a crucial role in copper uptake to the organism
[21], it is plausible that its dysfunction in ms/2 male mice may
result in impaired copper delivery to erythroid precursors and in
consequence, low copper levels in peripheral erythrocytes. Indeed,
measurement of the copper concentration in circulating ms/2
erythrocytes showed a decrease of about 60% compared with that
of healthy controls. This decrease correlated strongly with the
down-regulation of both SOD1 expression (30%) and activity
(70%). A reduction in erythrocyte SOD1 activity in response to
dietary copper deficiency has been described in various mamma-
lian species [53–55] including mice [39]. Obviously, altered
functioning of Cu,Zn-SOD increases the risk of oxidative stress.
With regard to erythrocytes, this phenomenon is well documented
in SOD1 null mice, in which the lack of Cu,Zn-SOD activity is
responsible for increased oxidative stress in circulating erythro-
cytes [30,56] and the production of autoantibodies against
erythrocytes [30]. These events were found to be causally
connected with the increased sensitivity of erythrocytes to
Figure 6. Hepatic and renal iron status in control (+/2) and mutant (ms/2) mice. Non-haem hepatic (A) and renal (C) iron content was
measured as described in the Experimental section. Values are expressed as the means 6 S.D. for both liver and kidney samples obtained from 15
mice of each genotype. L-ferritin levels in hepatic (B) and renal (D) cytosolic protein extracts (50 mg/lane) were assessed by western blot analysis left-
hand panels. The blots were reprobed with polyclonal anti-human actin antibody as a loading control. (B) and (D) right-hand panels Immunolabelled
ferritin bands from four mice were quantified using a Molecular Imager and ferritin protein levels (means 6 S.D.) are plotted in arbitrary units. ** – P,
0.01.
doi:10.1371/journal.pone.0107641.g006
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oxidative injury and haemolysis [30,31]. Although ms/2 erythro-
cytes still display about 30% of normal SOD1 activity, the serum
obtained from these animals clearly has a haemolytic appearance.
The threshold level of SOD1 activity required to protect
erythrocytes against oxidative stress is unknown, although it was
previously shown that a decrease in SOD1 activity in Sod1+/2
erythrocytes to half of the value in Sod1+/+ cells is still sufficient to
ensure the protective activity of the enzyme [56]. Interestingly, ms/
2 male mice have a large number of acanthocytes (about 40%) in
the peripheral blood. Acanthocytosis may occur due to alteration
of the lipid composition and fluidity of the red cell membrane, but
can also be caused by dehydration in a subpopulation of
acanthocytic erythrocytes. Indeed, mosaic suckling males show
macroscopic signs of dehydration such as low body weight, loss of
liquids due to diarrhea, and increased density of the plasma. It is
worth noting that mild to moderate haemolysis was reported to be
associated with acanthocytosis [57]. One of the valuable hallmarks
of intravascular haemolysis is the disappearance of haptoglobin
(Hp) from the serum [40,41]. Hp is an acute-phase protein
involved in the clearance of haemoglobin (Hb) from the
bloodstream to prevent its toxicity [40,41]. When Hb is released
from ruptured erythrocytes, it is instantly bound by Hp and forms
a stable Hp-Hb complex [40,41], which is then rapidly removed
from the circulation by binding to the CD163 receptor, present
mainly on tissue macrophages including Kupffer cells [58]. Since
free Hp does not bind to CD163, specific recognition of the Hp-
Hb complex by this receptor explains the decrease in Hp
concentration in the plasma during accelerated haemolysis
[40,41]. However, in contrast to humans, the mouse CD163
may also directly bind Hb that is not complexed with Hp [59].
Nevertheless, we found that the serum of ms/2 mice was
completely depleted of Hp, suggesting that the Hb scavenging
mechanism functions very efficiently in these mutant males. The
next steps of Hb inactivation are its lysosomal degradation
followed by haem breakdown catalyzed by haem oxygenase 1
(HO1) [reviewed in 42]. Besides functioning as a substrate of
HO1, haem is known to be the most potent transcriptional inducer
of the Hmox1 gene [60]. Unsurprisingly, increases in the level of
both the HO1 transcript and protein were detected in the liver of
ms/2 mutants. Significantly, we previously found that the
expression of HO1 was also strongly induced in the liver of
Sod12/2 mice displaying moderate haemolytic anaemia [31].
Furthermore, transcriptional induction of hepatic HO1 was
observed under conditions of intravascular haemolysis in b-
thalassemic and sickle mice [29] as well as during malaria [61].
The identification of Kupffer cells as a site of hepatic HO1
expression in ms/2 mice strongly suggests that these cells are
mostly charged with the detoxification of haem derived from Hb
taken up from the bloodstream. HO1 also appears to be largely
responsible for haem catabolism during erythrophagocytosis [62].
Therefore, it is noteworthy that in agreement with the subcellular
localization of HO1 found in mouse bone marrow-derived
macrophages during erythrophagocytosis [62], immunostaining
of this enzyme was predominantly intracytosolic in the Kupffer
cells of ms/2 mice.
Studies on Hp-null mice showed that even under conditions of
physiological haemolysis, Hb is filtered by the kidneys [63]. Renal
filtration of Hb also occurs in normal subjects (mice and humans)
when the buffering capacity of Hp is overwhelmed in acute
haemolysis [40,41]. Studies in disease models demonstrated that
the kidney can adapt to increased amounts of Hb by inducing
HO1 [63]. Such a situation seems to occur in ms/2 mice. Indeed,
in the kidneys of these animals we showed a marked induction of
HO1 in cells of the renal tubules, very possibly as a consequence of
glomerular filtration of Hb. However, it is also possible that the
Hmox1 gene is induced in ms/2 mouse kidney in response to an
inflammatory reaction, the occurrence of which has been well
documented in the kidneys of 14-day-old mosaic males [43,44]. It
has recently been claimed that the protective antioxidant effect of
HO1 depends, at least in part, on co-induction of ferritin, a
cytosolic protein that binds, stores and thus detoxifies reactive iron
released by haem breakdown [64]. Accordingly, in both the liver
and kidneys of ms/2 males, ferritin was elevated at the protein
level compared to their healthy littermates. However, the Hmox1
gene might also be induced in the kidneys of ms/2 mice in
response to the inflammatory reaction caused by excessive copper
accumulation. Available data suggest a likely mechanism for this
copper overload. In the kidneys of healthy animals, copper
reabsorption from the urine occurs via the proximal renal tubules
[65,66]. Most of copper ions are then transferred back to the
circulation via ATP7A located in the basolateral membranes of
epithelial cells of these tubules [67]. This explains why dysfunction
of ATP7A protein in Atp7a mutants results in toxic copper
accumulation at the renal-proximal epithelium, a phenomenon
detected in various mouse models of Menkes disease [65,66],
including mosaic mice [43,44].
Apart from the induction of the Hp-CD163-HO1 pathway [42],
the adaptive changes in the iron metabolism under haemolytic
conditions also involve the redistribution of iron from macro-
phages back to the circulation. This process is mediated by
ferroportin (Fpn), the sole cellular exporter of ionic iron known in
mammalian cells [7]. We previously demonstrated that enhanced
expression of hepatic Fpn in haemolytic anemia in KO SOD1
mice ensures the iron supply required for erythropoiesis [31].
Surprisingly, in ms/2 mice, Fpn was down-regulated in Kupffer
cells, the principal cell type expressing Fpn in the liver. According
to the consensus of the hepcidin-ferroportin regulatory axis [7],
such down-regulation of Fpn expression strongly suggested the
concomitant up-regulation of hepatic hepcidin. Indeed, hepcidin
was elevated at the mRNA level by more than 10-fold in ms/2
mutants compared with control males. We hypothesize that the
renal inflammation induced in mosaic mice by heavy copper
overload [38,43,44] diffuses throughout the organism of ms/2
mice and mediates transcriptional activation of the Hamp gene in
the liver. Accordingly, it is well established that plasma hepcidin
levels remain persistently high in patients with chronic kidney
disease [68]. Furthermore, inflammatory mediators such as
interleukin-6 and -1 participate in the iron-independent induction
of the Hamp gene [69]. Despite increased and decreased
expression of HO1 and Fpn, respectively, we observed only a
tendency in both liver and kidney of ms/2 mice to accumulate
non-haem iron, although the elevated level of ferritin in both
organs seems to support some retention of iron in these tissues. It is
possible that the extent of iron loading in the two examined organs
is quite limited. A similar lack of global hepatic iron loading has
also been reported in haemolytic mice lacking Cu,Zn-SOD1 [31].
In summary, we have identified a new indirect relationship
between copper deficiency in the mouse model of Menkes disease
and systemic iron metabolism. The key point in this interconnec-
tion is decreased activity of the erythrocyte antioxidant cuproen-
zyme Cu,Zn-SOD, resulting in oxidative stress, increased perme-
ability of erythrocyte membranes and haemolysis. Hb released
from damaged erythrocytes causes the mobilization of a protective
system neutralizing Hb toxicity, including Hp-dependent elimina-
tion of Hb from the circulation as well as the degradation of haem
derived from Hb by HO1 in the liver and kidneys. Importantly,
our results show for the first time that suckling mice adapt their
iron metabolism to haemolytic insult in a similar manner to adult
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animals. Finally, haemolysis has been identified as an additional
pathological symptom in a mouse model of Menkes diseases.
It is largely known that similarly to mosaic mutants [44], Menkes
patients suffer from kidney and urinary tract dysfunctions and
develop chronic renal inflammation [70]. Increased hepcidin
synthesis under these pathological conditions may reduce avail-
ability of iron for erythropoiesis and in combination with
haemolysis may contribute for the development of anemia. Taking
together, our results point out a need to monitor iron status in
Menkes patients.
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31. Starzyński RR, Canonne-Hergaux F, Willemetz A, Gralak MA, Woliński J, et al.
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